Uswm Drug Patent Portfolio
Uswm owns 1 orange book drug protected by 1 US patent Given below is the list of Uswm's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12582625 | Methods For Treating Neuroblastoma | 12 Feb, 2036 | Active |
Uswm's Family Patents
Clinical Trials
Recent Clinical Trials by Uswm:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors | USWM CT, LLC | NA |
ACTIVE NOT RECRUITING
(Aug 1, 2026)
| PHASE2 |
| Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma | USWM CT, LLC | NA |
COMPLETED
(Aug 1, 2026)
| PHASE2 |
| Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma | USWM, LLC (dba US WorldMeds) | NA |
COMPLETED
(Apr 1, 2026)
| PHASE2 |
Uswm Drug List
Given below is the complete list of Uswm's drugs and the patents protecting them.
1. Iwilfin
Iwilfin is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12582625 | Methods For Treating Neuroblastoma |
12 Feb, 2036
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Iwilfin's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List